NeuroTimone Facility (PFNT)

The PFNT Facility is a coherent set of exploration tools in neurobiology allowing research at the molecular, cellular and integrated levels.

News

  1. Team 6 (Nivet) at NeuroMarseille's Day

    Team 6 was happy to participate in NeuroMarseille's day, which took place on June 28, 2022.

    Many members of the INP attended this scientific and friendly day for the neuroscience community. 

    Our M1 student, Marine Dos Santos, also presented her one-month work in our team, during the afternoon poster session. 

    We thank NeuroMarseille for this great day !

     

     

     

  2. Canceropole Annual Seminar in St Raphaël

    INP members from team 8 (GlioME: Gliomagenesis and MicroEnvironment) and team 9 (Cytoskeleton and Neurophysiopathology) attended the Canceropole PACA annual seminar which took place in Saint-Raphaël palais des congrés on July 5th and 6th 2022. 

  3. INP attending first MOSBRI meeting in Paris

    On the 20-22 nd June, the first Molecular Scale Biophysics Research Infrastructure (MOSBRI) conference was held in Paris. Dahbia Yatoui from team 9 and Géraldine Ferracci from PINT went to this event, where Dahbia had the opportunity to present her work "Role of zinc-binding sites in Tau aggregation" on a poster.

  4. Aurélie Tchoghandjian at the SunRise Congress

    The GlioME team was represented on 8 and 9 June 2022 at the Sunrise (Solid tumor cancer stem cell network) meeting at the Curie Institute in Paris. 

    Aurélie Soubéran presented a poster on the role of the ML-IAP protein in glioblastoma growth and Aurélie Tchoghandjian presented the team's work on "Smac mimetic as pan-cellular therapy in glioblastoma".

  5. INP Day 2022 : Team Nivet (6) was happy to attend !

    After two years of being postponed, INP Day #2 finally took place on Friday, June 3rd. 

    A huge congrats and thank you to the organizing team (including our engineer Louise) for persevering and making this day a success!

    Team 6 took the opportunity of this cheerful day to take a picture, with Marine our intern who is a M1 student. 

  6. Scientifica, la recontre des Arts et des Sciences
  7. La journée de l'INP à la rencontre de la fée bleue
  8. The GlioME team represented the institute at the Brain Tumor Meeting in Berlin

Pages

INP in numbers

  • 126 members
  • 44 researchers
  • 48 research assistants
  • 12 post-docs
  • 11 PhD

 

CMA-CGM funding obtained by Team 8

Team 8 has recently obtained a CMA-CGM funding in the framework of the call for projects "Programme d'équipement et de recherche clinique" 2022

The project title is "Program of Precision RAdioTherapy to Improve patient Cancer treatment" and aims to participate in the purchase of a small animal irradiator "SARRP" that will complement the pre-clinical offerings of the PETRA network.

Undefined

Amidex Blanc funding of a collaborative project between teams 8 and 9

 

Team 9 represented by José Luis and team 8 represented by Aurélie Tchoghandjian have obtained Amidex Blanc funding for the project: "Bioinspired cytotoxic copper complexes: deciphering their mechanism of action in cancer cells to develop efficient therapeutic agents (CytoCu4Cancer)".

This project is led by a chemist, Olga Iranzo of the Institute of Molecular Sciences of Marseille (iSm2).

Undefined

Tous et toutes au recyclage !

Depuis lundi 3 Avril, l'INP participe à une opération inter-laboratoires de quantification de déchets recyclables professionnels (et ménagers) sur le campus Timone. 
Pour cela, chaque aile a été aménagée avec des points de collecte et de tri sélectif. Chaque semaine, les différentes catégories seront pesées puis emmenées au recyclage pour valorisation. 

Undefined

Maud Gratuze, new team leader, first INP publication

In collaboration with the Holtzman lab., Maud Gratuze, with her colleagues Monica Xiong and Chao Wang, published an article on a project developed during her postdoc in the USA. In this study, entitled "Astrocytic APOE4 removal confers cerebrovascular protection despite increased cerebral amyloid angiopathy" and recently published in Molecular Neurodegeneration, they reduced ApoE4, the strongest genetic risk factor in Alzheimer’s disease, specifically derived from astrocytes in a mouse model of cerebral amyloid angiopathy.

Undefined

Partners